These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8288039)

  • 21. The pharmacology of aldose reductase inhibitors.
    Kador PF; Robison WG; Kinoshita JH
    Annu Rev Pharmacol Toxicol; 1985; 25():691-714. PubMed ID: 3923907
    [No Abstract]   [Full Text] [Related]  

  • 22. Aldose reductase in the etiology of diabetic complications. 3. Neuropathy.
    Stribling D; Armstrong FM; Perkins CM; Smith JC
    J Diabet Complications; 1989; 3(3):139-48. PubMed ID: 2528557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldose reductase and its inhibition in the control of diabetic complications.
    Narayanan S
    Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldose reductase inhibitors as pathobiochemical probes.
    Dvornik D
    J Diabetes Complications; 1992; 6(1):25-34. PubMed ID: 1562755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldose reductase and the etiology of diabetic cataracts.
    Varma SD
    Curr Top Eye Res; 1980; 3():91-155. PubMed ID: 6807610
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic analysis of aldose reductase in diabetic complications.
    Chung SS; Chung SK
    Curr Med Chem; 2003 Aug; 10(15):1375-87. PubMed ID: 12871135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic cataracts and flavonoids.
    Varma SD; Mizuno A; Kinoshita JH
    Science; 1977 Jan; 195(4274):205-6. PubMed ID: 401544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
    Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aldose reductase inhibitors and cataract.
    Crabbe MJ
    Int Ophthalmol; 1991 Jan; 15(1):25-36. PubMed ID: 1901300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sorbitol route of glucose metabolism and complication of diabetes mellitus].
    Efimov AS; Skrobonskaia NA; Petakh NN
    Probl Endokrinol (Mosk); 1980; 26(3):86-90. PubMed ID: 6773043
    [No Abstract]   [Full Text] [Related]  

  • 31. Discoveries in research on diabetic keratopathy.
    Cisarik-Fredenburg P
    Optometry; 2001 Nov; 72(11):691-704. PubMed ID: 12363257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The biochemical basis of the complications of diabetes].
    Gabbay KH
    Journ Annu Diabetol Hotel Dieu; 1984; ():307-20. PubMed ID: 6443221
    [No Abstract]   [Full Text] [Related]  

  • 33. Etiology of cataracts in diabetics.
    Varma SD; Richards RD
    Int Ophthalmol Clin; 1984; 24(4):93-110. PubMed ID: 6438012
    [No Abstract]   [Full Text] [Related]  

  • 34. Aldose reductase and sorbitol dehydrogenase distribution in substructures of normal and diabetic rat lens.
    Collins JG; Corder CN
    Invest Ophthalmol Vis Sci; 1977 Mar; 16(3):242-3. PubMed ID: 403152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of aldose reductase inhibitors in diabetic complications: recent trends.
    Kaul CL; Ramarao P
    Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR; Moriarty RJ; Mayer JH
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldose reductase and diabetic retinopathy.
    Singh R; Dash D; Ansari FJ; Maurya OP; Singh VP
    Ann Ophthalmol; 1992 Nov; 24(11):420-2. PubMed ID: 1476398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats.
    Yagihashi S; Kamijo M; Ido Y; Mirrlees DJ
    Diabetes; 1990 Jun; 39(6):690-6. PubMed ID: 2140802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.